That is very important, because the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (diplomatic relations). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. This was a development nearly nobody discovered. But it's going to have profound ramifications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of investment chances in this space, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown predictions 2021). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly substantially before going greater - future report. I've been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. However that's not the big question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. jeff brown genome sequencing. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many great private business on the edge of striking the general public markets And I have actually been dealing with a new way for you to invest even before these companies go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your spot free of charge.
Emma Walsh here, handling editor of the Journal. Regular Journal readers understand that tech isn't our usual beat (social media). And when it comes to tech investing, we leave it to the professionals. Fortunately, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we know (jeff bezos). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing rapid development and producing amazing chances for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown stock picks 2021. However in spite of what lots of readers may believe, this is a pattern that's just getting begun. Even though the COVID-19 pandemic interfered with supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown 2020 predictions). Losing two months of manufacturing and sales really impacts how lots of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million systems is exceptional. More importantly, the delays triggered by the pandemic produced a load of bottled-up demand. And that demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - longtime readers. And that's not my only 5G forecast When I've discussed 5G in the past, I've described its 3 different phases.
In Phase Two, 5G gadgets go on sale. 5G phones and other products start to reach customers. And in Phase Three, 5G services begin to be used (jeff brown stock market prediction). That's when we begin to see applications working on 5G networks. Consider things like huge multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase 3 by this summertime. This starts something of a virtuous cycle: The majority of people don't really appreciate the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open up a suite of unbelievable applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment chances going forward will be enormous. Stepping far from 5G, the next important innovation I predict in 2021 is CRISPR genetic modifying. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR uses a similar concept however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche technology that wasn't well understood. And throughout that time, there were actually only three companies running in this area. However things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're dealing with illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is effectively a greenfield chance.
There's room for many companies to exist in this space. jeff brown investor prediction. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can precisely forecast the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is necessary due to the fact that the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been an experimental procedure. Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're designed to do. And here's my next forecast. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however numerous drug treatments produced utilizing this technology. This was one of those breakthroughs that almost nobody saw. But it's going to have extensive ramifications for treating disease. And, naturally, there will be plenty of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back perhaps considerably before going higher. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin - jeff brown. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. jeff brown predictions for 2021. Mass, Mutual is a 150-year-old institution. So think about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the info depends on date since February 2021, however we might not independently confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to pick winning technology stocks. He spent more than 25 years investigating innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an exceptional viewpoint on the marketplace. He's constantly on the hunt for new chances, and he shares a lot of his finest picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he successfully forecasted some of the greatest economic occasions of the previous 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it right every time, however Jeff Brown's accurate forecasts have actually made him legions of dedicated followers. That states a lot about his ability. The Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research uses several research study services with a wide range of specializations - jeff brown latest prediction.
The business is likewise associated with Bonner & Partners, another well-respected research publisher - legacy report prediction. On its site, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the best investment research has not been offered to individual financiers. It has been usually scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown biotech stock pick for 2020. The objective of Brownstone Research is to make that kind of exclusive research available to any investors aiming to acquire an edge in the markets. The objective is easy to provide distinct and lucrative financial investment research study found nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise serves as the firm's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. black sea. Whatever he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown thinks S.A.V. jeff brown top biotech stock 2021. might be "the most significant pattern of the 2020s, and he's not alone. Inspect out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding two advanced technologies: expert system and electric cars. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the vehicle industry's Holy Grail. As you understand, electrical cars and self-driving car stocks have actually been huge this year, but the Wall Street maker has approved hype without much tangible outcome. Regardless of a drastic boost in competition over the previous few years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech could be the magic string that ties all of it together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Basically, this technology would allow you to rent your vehicle as a self-governing, self-driving taxi when you're not using it. You just leave the vehicle and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your car shuttles ride-sharers around town. Best of all, you get to keep a substantial piece of the profits. It sounds ridiculous, but it could be closed than you believe.